| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.566 | 11.559 | 10.114 | 5.372 | 363.064 | 99.560 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 4.566 | 11.565 | 10.114 | 5.856 | 373.924 | 106.848 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 6.129 | 1.284 | 394 | 5.205 | 18.244 | 10.205 | 1.346 | 53.893 | 0 | 0 |
| Gross Profit/Loss - EUR | -1.564 | 10.281 | 9.720 | 651 | 355.680 | 96.643 | -1.346 | -53.893 | 0 | 0 |
| Net Profit/Loss - EUR | -1.701 | 9.934 | 9.415 | 598 | 355.633 | 95.628 | -1.346 | -53.893 | 0 | 0 |
| Employees | 2 | 1 | 1 | 1 | 3 | 2 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Orosz Intermed Consulting Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 790 | 782 | 769 | 754 | 740 | 726 | 710 | 0 | 0 | 0 |
| Current Assets | 22.033 | 20.477 | 29.391 | 30.347 | 387.394 | 380.475 | 363.302 | 3 | 3 | 3 |
| Inventories | 2.107 | 2.085 | 2.050 | 2.012 | 1.973 | 1.936 | 1.893 | 0 | 0 | 0 |
| Receivables | 19.928 | 14.226 | 21.313 | 20.937 | 96.904 | 64.091 | 62.003 | 3 | 3 | 3 |
| Cash | -2 | 4.165 | 6.028 | 7.398 | 288.516 | 314.448 | 299.407 | 0 | 0 | 0 |
| Shareholders Funds | 11.171 | 20.991 | 30.051 | 30.097 | 385.148 | 366.602 | 357.127 | -68.764 | -68.555 | -68.172 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 11.045 | 267 | 108 | 1.005 | 2.986 | 14.599 | 6.885 | 68.767 | 68.558 | 68.175 |
| Income in Advance | 607 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4339 - 4339" | |||||||||
| CAEN Financial Year |
8299
|
|||||||||
Comments - Orosz Intermed Consulting Srl